The Pharma Data

DECEMBER 14, 2020

14, 2020 (Healthday News) — The first shipments of nearly 3 million doses of the Pfizer coronavirus vaccine were on their way to hospitals in all 50 U.S. Because the vaccines can cause side effects including fevers and aches, hospitals have said they will stagger vaccinations among their workers. MONDAY, Dec.

Vaccine 52

Vaccine Nurses Assisted Living Hospitals 52

Codon

JANUARY 21, 2024

Human challenge trials were an indispensable part of the development of the malaria vaccine, R21/Matrix-M, endorsed by the World Health Organization last October. But for all of their benefits, human challenge trials have their drawbacks. Jake himself has participated in both Zika and Shigella challenge trials.

Vaccine 111

Vaccine Trials Disease Virus 111

The Pharma Data

JANUARY 12, 2021

Doses are being supplied for use pursuant to the FDA Emergency Use Authorization for high-risk patients with mild to moderate COVID-19 in order to reduce the risk of progression to severe COVID-19 and/or hospitalization. To date, nearly 15,000 people have participated in casirivimab and imdevimab clinical trials. Yancopoulos , M.D.,

Government 52

Government Hospitals Virus Production 52

The Pharma Data

DECEMBER 4, 2020

And I think we’ll see a significant reduction” in the virus, Biden told CNN. That response is facing its toughest challenge so far, as daily case counts, hospitalizations and deaths continue to set records on a daily basis. “If we don’t act now our hospital system will be overwhelmed,” Gov.

Long-Term Care Facilities 52

Long-Term Care Facilities Vaccine Nurses Hospitals 52

The Pharma Data

DECEMBER 14, 2020

Food and Drug Administration issued the EUA for use of the vaccine in individuals ages 16 years and older late Friday evening, allowing a national vaccine campaign against the virus to begin this week. Centers for Disease Control and Prevention Director Robert R. Redfield, M.D., The vaccine is administered in two doses three weeks apart.

Vaccine 52

Vaccine Nurses FDA Virus 52

The Pharma Data

DECEMBER 11, 2020

Health care workers and nursing home residents and staff should get the first shots, according to guidelines issued recently by the U.S. Instead, a modified version of the vaccine will be tested in a smaller trial set to begin in February, the newspaper said. Third of Americans live where hospitals are short on ICU beds.

Vaccine 52

Vaccine FDA Hospitals Doctors 52

The Pharma Data

DECEMBER 2, 2020

Still, the temperature requirement could dictate who will be vaccinated first in Britain: While nursing home residents were supposed to be the top priority under an advisory committee’s plans, efforts to limit transportation of the vaccine may mean that National Health Service staff will receive the shots first, the Times reported.

Vaccine 40

Vaccine Long-Term Care Facilities Hospitals Nurses 40

The Pharma Data

JANUARY 11, 2021

million, will boost its vaccine rollout to now include health care workers, nursing home residents and staff, as well as those living in congregate settings such as assisted living or shelters. Herd immunity will be reached when the virus encounters enough people with immunity that it dies out. The clock is ticking.” But the U.S.

Vaccine 52

Vaccine Virus Assisted Living Nurses 52

The Pharma Data

DECEMBER 3, 2020

The TAK-620-303 (SOLSTICE) trial (NCT02931539) is a multicenter, randomized, open-label, active-controlled trial comparing eight weeks of treatment with either maribavir or investigator assigned treatment (IAT) in transplant recipients with CMV infection refractory or resistant to existing antiviral treatments (i.e., About Maribavir.

Treatment 52

Treatment Pharmaceutical Companies Therapies Virus 52

The Pharma Data

JANUARY 26, 2021

“The death toll from COVID-19 continues to rise around the world and hospitalizations, particularly in the U.S., These data further support our belief that bamlanivimab and etesevimab together have the potential to be an important treatment that significantly reduces hospitalizations and death in high-risk COVID-19 patients.

Hospitals 52

Hospitals Treatment Long-Term Care Facilities Trials 52

The Pharma Data

NOVEMBER 20, 2020

The clinical evidence from Regeneron’s outpatient trial suggests that monoclonal antibodies such as casirivimab and imdevimab have the greatest benefit when given early after diagnosis and in patients who have not yet mounted their own immune response or who have high viral load. Yancopoulos, M.D.,

Therapies 52

Therapies FDA Clinical Trials Hospitals 52

The Pharma Data

NOVEMBER 18, 2020

18, 2020 /PRNewswire/ — Tampa General Hospital provided the first monoclonal antibody treatment to a COVID-19 positive patient today. It works to block the “spike protein” in the virus before it can enter human cells and cause illness. TAMPA, Fla.,

Hospitals 40

Hospitals Treatment Virus Nurses 40

The Pharma Data

NOVEMBER 21, 2020

The clinical evidence from Regeneron’s outpatient trial suggests that monoclonal antibodies such as REGEN-COV2 have the greatest benefit when given early after diagnosis and in patients who have not yet mounted their own immune response or who have high viral load. Yancopoulos , M.D., President and Chief Scientific Officer of Regeneron.

FDA 40

FDA Clinical Trials Hospitals Government 40

The Pharma Data

JANUARY 26, 2021

Eli Lilly expanded its ongoing BLAZE-4 study to include Vir’s monoclonal antibody in the trial. Data published last week showed that bamlanivimab significantly reduced COVID-19 risk for nursing home residents in a Phase III trial. . Food and Drug Administration to treat mild-to-moderate COVID-19 patients.

Virus 52

Virus Nurses Research Laboratories Trials 52

The Pharma Data

JANUARY 24, 2021

With a presidential inauguration and a federal holiday, it wasn’t an enormously busy week for clinical trial news, but there was a fair amount, nonetheless. It inked a deal with the National Institute of Allergy and Infectious Diseases (NIAID) to launch a Phase I trial. Read on to see. COVID-19-Related. Non-COVID-19-Related.

Long-Term Care Facilities 52

Long-Term Care Facilities Trials Virus Clinical Trials 52

The Pharma Data

NOVEMBER 24, 2020

And when you do, it’s normal that you have some arm soreness or some fatigue or some body aches or even some fever,” Patricia Stinchfield of Children’s Hospitals and Clinics of Minnesota, told the meeting of the CDC’s Advisory Committee on Immunization Practices. Meanwhile, U.S. effective, The New York Times reported.

Vaccine 52

Vaccine Virus Immune Response Hospitals 52

The Pharma Data

DECEMBER 18, 2020

“To go from having a [genetic] sequence of a virus in January, to having two vaccines available in December, is a remarkable achievement.” Moderna’s vaccine was shown to be 94 percent effective in its large clinical trial, while Pfizer’s vaccine was 95 percent effective. ” Earlier this week, Gen.

Vaccine 52

Vaccine FDA Government Hospitals 52

The Pharma Data

DECEMBER 21, 2020

This latest strain of coronavirus is concerning because it has so many mutations — nearly two dozen — and some are on the spiky protein that the virus uses to attach to and infect cells, the AP reported. The new COVID-19 vaccines target that spiky protein. billion, the Post reported. Meanwhile, Brazil had over 7.2

Vaccine 52

Vaccine Government Hospitals FDA 52

The Pharma Data

DECEMBER 22, 2020

He did so live on television at ChristianaCare Hospital in Newark, Del. Instead, it may have been identified there first because the British government has a strong monitoring system that has tracked tens of thousands of genomic sequences of virus samples. “It may very well be here. It may have even started here.

Packaging 52

Packaging Vaccine Government Hospitals 52

The Pharma Data

DECEMBER 31, 2020

Right now, most shots are being given at hospitals, clinics and nursing homes, but Perna and Slaoui agreed that the pace of vaccination should pick up considerably once doses are given out by the major pharmacy chains. But a faster-spreading virus could swamp hospitals with seriously ill patients. .

Vaccine 52

Vaccine Long-Term Care Facilities Virus Hospitals 52

The Pharma Data

JANUARY 13, 2021

. “Every vaccine dose that is sitting in a warehouse rather than going into an arm could mean one more life lost or one more hospital bed occupied.” Right now, the vaccines are largely being distributed to people in the highest-risk categories, including frontline health care workers and older people and staff in nursing homes.

Vaccine 52

Vaccine Government Virus Nurses 52

The Pharma Data

DECEMBER 23, 2020

That includes two companies — Sanofi and Novavax — that have yet to begin large clinical trials in the United States. Instead, it may have been identified there first because the British government has a strong monitoring system that has tracked tens of thousands of genomic sequences of virus samples.

Vaccine 52

Vaccine Government Virus Medical Schools 52